Cargando…

Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial

The aim of this study was to evaluate the efficacy and safety of recombinant human adenovirus-p53 (rhAd-p53) combined with neoadjuvant chemotherapy in treatment of locally advanced cervical cancer (LACC). A total of 40 patients with LACC (stage IB2 to IIIA) were randomized into 2 groups (n=20 each):...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Jie, Zhou, Jian, Fu, Min, Liang, Li, Deng, Qiaoling, Liu, Xiaoyun, Liu, Fumin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431581/ https://www.ncbi.nlm.nih.gov/pubmed/28529585 http://dx.doi.org/10.3892/ol.2017.5901

Ejemplares similares

Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis
por: Guo, Yaru, et al.
Publicado: (2021)

Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis
por: Liu, Yehong, et al.
Publicado: (2016)

Combined effect of recombinant human adenovirus p53 and curcumin in the treatment of liver cancer
por: Qu, Juan, et al.
Publicado: (2020)

Recombinant adenovirus-p53 enhances the therapeutic effect of surgery and chemoradiotherapy combination in hypopharyngeal squamous cell carcinomas patients
por: Liu, Jun, et al.
Publicado: (2018)

Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells
por: Li, Li-xia, et al.
Publicado: (2013)

The Efficacy and Response Predictors of Platinum-Based Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
por: Huang, Yuhui, et al.
Publicado: (2020)

A Recombinant Human Adenovirus Type 5 (H101) Combined With Chemotherapy for Advanced Gastric Carcinoma: A Retrospective Cohort Study
por: Zhang, Ran, et al.
Publicado: (2021)

Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
por: Sugiyama, T, et al.
Publicado: (1999)

Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer
por: Liu, Guiyuan, et al.
Publicado: (2022)

Neoadjuvant chemotherapy for locally advanced cervical cancer
por: Iwata, Takashi, et al.
Publicado: (2016)

Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion
por: Biaoxue, Rong, et al.
Publicado: (2016)

Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
por: Watanabe, Maki, et al.
Publicado: (2021)

Corrigendum: A Recombinant Human Adenovirus Type 5 (H101) Combined With Chemotherapy for Advanced Gastric Carcinoma: A Retrospective Cohort Study
por: Zhang, Ran, et al.
Publicado: (2022)

Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer
por: Yu, Xiao-Li, et al.
Publicado: (2021)

The Efficacy of Volumetric Modulated Arc Therapy Combined With Chemotherapy, Brachytherapy, and Local Hyperthermia on Patients with Locally Advanced Cervical Cancer: A Retrospective Study
por: Jiang, Ping, et al.
Publicado: (2023)

Expression of HIF-1α is a predictive marker of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer
por: Yan, Bin, et al.
Publicado: (2020)

Radiotherapy Versus Chemotherapy in Locally Advanced Cervical Cancer
por: Patel, Drashti, et al.
Publicado: (2023)

The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer
por: Liu, Xing, et al.
Publicado: (2004)

Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma
por: Scandurra, Giuseppa, et al.
Publicado: (2015)

Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature
por: Liu, Linlin, et al.
Publicado: (2023)

Efficacy and safety of nimotuzumab combined with chemoradiotherapy in the treatment of locally advanced cervical cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis
por: Yuan, Cheng, et al.
Publicado: (2016)

Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers
por: Li, Yi, et al.
Publicado: (2021)

Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy
por: Li, Shuwen, et al.
Publicado: (2017)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis
por: Wang, Jincheng, et al.
Publicado: (2022)

Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis
por: Zeng, Wei, et al.
Publicado: (2022)

Complement activation by recombinant adenoviruses
por: Cichon, G, et al.
Publicado: (2002)

Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis
por: Feng, Li, et al.
Publicado: (2021)

Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer
por: Lu, Heming, et al.
Publicado: (2022)

Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer
por: Chen, Yong-Fa, et al.
Publicado: (2017)

Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck
por: Yang, Hua, et al.
Publicado: (2013)

Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination
por: Sato-Dahlman, Mizuho, et al.
Publicado: (2020)

The Safety and Efficacy of Intra-Arterial versus Intravenous Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer: A Meta-Analysis
por: Liu, Cheng, et al.
Publicado: (2020)

Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement
por: Wang, Yue, et al.
Publicado: (2011)

A review of topotecan in combination chemotherapy for advanced cervical cancer
por: Robati, Minoo, et al.
Publicado: (2008)

Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken
por: Gupta, Sudeep
Publicado: (2019)

Is There a Place for Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer?
por: Čerina, Dora, et al.
Publicado: (2022)

Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2023)

In vivo Recombinant Adenovirus-mediated p53 Gene Therapy in a Syngeneic Rat Model for Colorectal Cancer
por: Baek, Jeong-Heum, et al.
Publicado: (2004)

Assessment of retroperitoneal lymph node status in locally advanced cervical cancer
por: Li, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8b5lq9tj4bbr9fv6lbokmio4p9